美国Genomic Solutions www.genomicsolutions.com
Genomic Solutions依托哈佛大学的生命科学技术，成立于1901年，是纳斯达克上市公司，后又收购了著名的芯片点样仪生产厂家Cartesion和GeneMachines，成为基因组、蛋白质组学领域的著名仪器生产商。从基因组学的核酸的分装、点样、扫描成像、数据分析到蛋白组学的二维电泳、自动切胶、蛋白酶解、点样、数据分析，都提供完整的自动化仪器。公司产品面向60多个国家和地区，近五年的公司年增长率达到38%，成为国际知名的生命科学仪器生产商。

Genomic Solutions® designs, develops, and manufactures genomic and proteomic instrumentation, software, consumables and services. We are the only company supplying tools and expertise for genomics, proteomics, and low-volume liquid handling.
Our instruments can be purchased individually or as part of fully integrated systems tailored to genomic, proteomic and drug discovery research requirements. Our customers use our integrated, automated systems to facilitate more rapid and less expensive drug discovery. Genomic Solutions® products provide high quality research data and fast turnaround time. Now, as part of the Harvard Bioscience family of companies, Genomic Solutions® and Union Biometrica are proud to offer complete solutions to life science research needs.
Company History
Genomic Solutions® was formed in 1997 to address the emerging research needs for innovative, first to market automated genomic and proteomic instruments. 
A series of strategic acquisitions combined with internal R&D, resulted in the release of the comprehensive GeneTAC TM Biochip and Investigator TM Proteomic systems in 1999 and 2000 respectively. 
Genomic Solutions® became a publicly held company with a highly successful initial public offering (Nasdaq NM: GNSL), May 2000. 
Through a series of strategic alliances, product development initiatives and timely organizational refinements, the company bolstered its market position as a single-source supplier of tools and services for both genomic and proteomic researchers. 
During the fourth quarter of 2001, Genomic Solutions® acquired Cartesian Technologies, Inc., further strengthening product choices available to customers and additionally moving the company into the emerging high-throughput screening market. 
During the fourth quarter of 2002, Genomic Solutions® was acquired by Harvard Bioscience (Nasdaq: HBIO) and became a wholly owned subsidiary of HBIO. 
During the first quarter of 2003, Genomic Solutions® acquired GeneMachines (San Carlos, CA), further enhancing market strength in microarray technology. 
During the third quarter of 2003, Genomic Solutions® acquired BioRobotics (UK), solidifying market strength and position in microarray technology.